The method is based on the detection of Chlamydia trachomatis antigens in urethral, cervical, and conjunctival swabs using ELISA with visual assessment of the results (sensitivity over 79%, specificity over 95%). This method relies on the presence of a genus-specific lipopolysaccharide antigen in chlamydia.